Roche's Prasinezumab Heads to Phase III for Early-Stage Parkinson's

Roche has reported it will move prsazinezumab, its investigational anti-alpha-synuclein antibody, into Phase III development for early-stage Parkinson’s disease following an assessment

FQPL Pharma Leaders' National Meet Set for June 21

The Forum for Quality Pharma Leaders (FQPL), will hold its national meeting on June 21 at the JSS College of Pharmacy at JSS Academy of Higher Education and Research (JSSAHER)...

Lupin signs deal with China's SUP for Tiotropium DPI rollout

Pharmaceutical company Lupin Ltd announced that it has entered into a licensing and supply agreement with China's Sino Universal Pharmaceuticals (SUP) for marketing Tiotropium dry...

Innovation on Display: London Biotechnology Show 2025 Returns in 2 days

In just two days, the second edition of the London Biotechnology Show (LBS) returns to ExCeL London on 18–19 June, bringing together one of the most influential gatherings in the global biotechnology calendar. The event promises cutting-edge science

DBT Invites Proposals for Green Biomanufacturing of APIs & Chemicals

Under its BioE3 (Biotechnology for Economy, Environment, and Employment) policy, which aims to promote high-performance biomanufacturing, the Department of Biotechnology (DBT) intends to support the biomanufacturing of active pharmaceutical

India's Pharma Sector Faces Heightened FDA Scrutiny on Quality

India's domestic pharmaceutical industry will be subject to heightened scrutiny in light of ongoing quality control issues among domestic manufacturers, a reported by BMI stated...

Gujarat to Host Global Pharma Delegation on June 18 in Ahmedabad

Gujarat will soon be able to share its strong pharmaceutical and healthcare ecosystem with the world through an international delegation from 41 countries on June 18, 2025. The visit is part of the 2nd...

Regulators Urge NITI Aayog to Form Task Force on Fake Medicines

The alarming surge in fake medicines detected across multiple Indian states has stimulated drug regulators to push for immediate, forceful intervention to protect public health and restore trust in the country’s pharmaceutical ecosystem.

Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks

Eli Lilly's experimental obesity drug, eloralintide, has shown promising early-stage data supporting weight loss of an average of 11.5 percent after only 12 weeks, said an investor note from Cantor Fitzgerald...

IOL Pharma Secures EcoVadis Silver Medal for Boosting Green Practices

IOL Chemicals and Pharmaceuticals Limited has been honored with a Silver Medal by EcoVadis, achieving a creditable score of 71 and obtaining a position in the 89th percentile among companies evaluated worldwide.

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.